A PILOT STUDY OF PIOGLITAZONE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AL GHARABALLY A.; O BRIEN CH.B.; ACOSTA R.C.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2007 | Volume:7 | Issue:3 Page(s): 131-137

Download Full-Text

View:

365

Download:

353

Cites:

Information Journal Paper

Title

A PILOT STUDY OF PIOGLITAZONE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

Author(s)

AL GHARABALLY A. | O BRIEN CH.B. | ACOSTA R.C. | Issue Writer Certificate

Keywords

NAFLD

NASH

BODY MASS INDEX

PIOGLITAZONE

Abstract

Background and Aims: Insulin resistance appears to be a major factor involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). In this pilot study, we examined the effect of PIOGLITAZONE, an insulin-sensitizing agent, on patients with NAFLD and NASH.Methods: The medical records of patients referred to our clinic over a 48-month period were reviewed, and individuals with a clinical diagnosis of NAFLD or NASH, who were overweight (BMI³25) with chronic elevated liver enzymes were included in this study. The patients were either treated with PIOGLITAZONE or advised to start a weight-reduction diet and exercise, in a non-blinded random method based on the treating physicians' discretion.Results: Thirty-four patients' charts were retrospectively analyzed. Nineteen patients were treated with PIOGLITAZONE and 15 patients were advised to start a weight reduction diet and exercise. There were significant improvements in mean ALT and AST in the PIOGLITAZONE group at the end of treatment when compared to pretreatment values and to the diet/exercise group. There were no significant changes in the lipid profiles, BODY MASS INDEX or fasting glucose levels between baseline and at the end of the therapy in either group. There were no adverse side effects, including hypoglycemia, in patients treated with PIOGLITAZONE.Conclusions: Preliminary results using PIOGLITAZONE in patients with NAFLD or NASH are promising. However, larger prospective studies are further needed to validate the results of our study and to examine histological response.

Cites

No record.

References

No record.

Cite

APA: Copy

AL GHARABALLY, A., O BRIEN, CH.B., & ACOSTA, R.C.. (2007). A PILOT STUDY OF PIOGLITAZONE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE. HEPATITIS MONTHLY, 7(3), 131-137. SID. https://sid.ir/paper/306130/en

Vancouver: Copy

AL GHARABALLY A., O BRIEN CH.B., ACOSTA R.C.. A PILOT STUDY OF PIOGLITAZONE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE. HEPATITIS MONTHLY[Internet]. 2007;7(3):131-137. Available from: https://sid.ir/paper/306130/en

IEEE: Copy

A. AL GHARABALLY, CH.B. O BRIEN, and R.C. ACOSTA, “A PILOT STUDY OF PIOGLITAZONE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE,” HEPATITIS MONTHLY, vol. 7, no. 3, pp. 131–137, 2007, [Online]. Available: https://sid.ir/paper/306130/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops